Important new insights into how the brain compensates for temporary hearing loss during infancy, such as that commonly experienced by children with glue ear, are revealed in a research study in ferrets. The Wellcome Trust-funded study at the University of Oxford could point to new therapies for glue ear and has implications for the design of hearing aid devices.
Lens-Free Imaging Technique Dramatically Extends Research Capabilities into Cells, Bacteria, and VirusesJune 27, 2013 12:48 pm | by Business Wire | Comments
CEA-Leti today introduced a new video lens-free imaging technique that redefines bio imaging, provides significant advantages over traditional microscopy, and opens a new range of capabilities for researchers, such as real-time monitoring of cell cultures.
To reduce the need for second surgeries, four Johns Hopkins graduate students have designed a device to allow pathologists to quickly inspect excised breast tissue within 20 minutes, while the patient is still in the operating room. If this inspection indicates that the tumor was not fully removed, additional tissue can then be removed during the same operation.
People who have a traumatic brain injury (TBI) may be more likely to have a future stroke, according to research that appears in the June 26, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The antibacterial effects of silver are well established. Now, researchers at Yonsei University in Seoul, Republic of Korea, have developed a technique to coat glass with a layer of silver ions that can prevent growth of pathogenic bacteria including Escherichia coli, Salmonella typhimurium and Campylobacter jejuni. The technology could be used to protect medical equipment.
Engineers and biologists at the University of Sheffield have shown how a recent theory-- that skin has 'sleeping' stem cells which can be woken up when required-- best explains how our skin constantly regrows. The research-- conducted in collaboration with The Procter & Gamble Company (P&G), makers of Olay, and published in Nature Scientific Reports-- has implications for combating the effects of aging and perhaps even skin cancer.
Our present understanding of thermodynamics is fundamentally incorrect if applied to small systems and needs to be modified, according to new research from University College London (UCL) and the University of Gdańsk. The findings, published today in Nature Communications, have wide applications in small systems, such as biological motors and systems found in the body.
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and launch of the Accent MRI ™ Pacemaker and the Tendril MRI ™ lead.
Implanted Blood Access Devices for Hemodialysis - Draft Guidance for Industry and Food and Drug Administration StaffJune 27, 2013 12:00 am | by U.S. Food & Drug Administration | Comments
This draft guidance document provides draft recommendations for complying with special controls being proposed to support reclassification of the Implanted Blood Access Devices for Hemodialysis into class II (special controls). The device, as proposed...
CEA-Leti and nine partners in the NEPHRON+ project are developing an artificial kidney that would provide a major improvement in treating patients with chronic kidney failure. The goal is a next-generation, integrated system that allows real-time, continuous, multiparametric monitoring of the patient and the device via sensors developed by Leti and its partners.
In June 2013, Medtronic, Inc. (NYSE: MDT) initiated four medical device notifications to customers worldwide about the SynchroMed® Implantable Infusion System. These notifications provide clinicians with information to help identify and manage issues that impact the safe and reliable delivery of therapy using the SynchroMed Implantable Infusion System.
Soon, women in Europe may be taking a new look at one of the world’s oldest forms of contraception. European regulators have granted the single-size SILCS Diaphragm a CE marking, allowing the product to be sold throughout Europe. The launch is also an important step toward expanding nonhormonal contraception options for women worldwide.
Axio Biosolutions Private Limited, a medical device designer and manufacturer company is proud to announce that it has obtained the European Union Class III Medical Device CE mark approval for its range of Emergency Haemostatic Dressing - AXIOSTAT. The CE mark designation will allow AXIOSTAT to be sold in the European Union and other countries.
Tangent Medical, an innovator in IV therapy products and creator of the NovaCath Integrated IV Catheter System, announced today its commercial product launch and start to clinical evaluations in several healthcare facilities across the U.S. The commercialization of this product is the first significant advancement in the IV catheter market in more than a decade.
Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised $8.5M in a Series A financing. The round was co-led by healthcare investment specialists Wellington Partners and Seventure Partners, along with seed investor High-Tech Gründerfonds Management GmbH (HTGF).